We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Laser Incubator Developed for Rapid Blood Group Typing

By LabMedica International staff writers
Posted on 01 Oct 2019
Print article
Image: The Eclipse Immunohematology Analyzer incorporates STARGEL10 AUTO Card Stacker technology enabling the loading of 32 STARGEL10 AUTO cards at once (Photo courtesy of Haemokinesis).
Image: The Eclipse Immunohematology Analyzer incorporates STARGEL10 AUTO Card Stacker technology enabling the loading of 32 STARGEL10 AUTO cards at once (Photo courtesy of Haemokinesis).
Blood transfusion is a critical treatment for a variety of hematological conditions, including cancer chemotherapy, sickle cell disease treatments, bleeding trauma, including childbirth, and major surgery.

Over 21 million blood components are transfused in the USA alone every year; each having the potential for fatal hemolytic transfusion reactions if recipient and donor are not accurately matched. Identification of antigens and antibodies often requires incubation at human body temperature of 37 °C. Depending on the method, this incubation step can take 5 to 30 minutes.

Chemical Engineers at Monash University (Clayton, Australia) and their colleagues at Haemokinesis (Hallam, Australia) developed rapid optical heating via laser, where targeted illumination of a blood-antibody sample in a diagnostic gel card is converted into heat, via photothermal absorption. The laser-incubator heats the 75 µL blood-antibody sample to 37 °C in less than 30 seconds.

Whole blood samples were stored by refrigeration at 4 °C with ethylenediaminetetraacetic acid (EDTA) as anticoagulant and were used within two weeks post-collection. Reagent red blood cell solutions (Haemokinesis: Stargel10 3 cell screen,) were used for all RBC-antibody incubation tests. Immunoglobulin-G (IgG) anti-D antibody was used for all antibody tests except for the sensitivity control test. The RBC-antibody mixtures were prepared directly in the gel card wells (Haemokinesis Stargel10 AHG System). The gel card heating block (Prototype #5, Haemokinesis) has a fixed temperature of 37 °C. Temperature was detected during incubation directly inside the sample volume in a gel card well using a thermocouple probe.

The team showed that red blood cells act as photothermal agents under near-infrared laser incubation, triggering rapid antigen-antibody binding. They detected no significant damage to the cells or antibodies for laser incubations of up to fifteen minutes. They demonstrate laser-incubated immunohaematological testing to be both faster and more sensitive than current best practice, with clearly positive results seen from laser incubations of just 40 seconds.

Clare A. Manderson, PhD, the first author of the study, said, “Giving blood transfusions to people isn't as simple as giving O-negative to anybody. The 'universal donor' of O-negative blood can seriously harm a lot of people, even kill them. The world of pre-transfusion of blood group typing is huge, and it's really important that it's done quickly and accurately to help save lives.” The study was originally published online on August 2, 2019, in the journal Scientific Reports.

Related Links:
Monash University
Haemokinesis

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
Creatine Kinase-MB Assay
CK-MB Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.